Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;335:578 (22 September), doi:10.1136/bmj.39332.459942.3A
| The first 100% of the full text of this article appears below. |
I was intrigued by the choice of antidepressant for this gorilla.1 Is escitalopram on the zoo's formulary? It is not on our local NHS formulary. Escitalopram is an s-enantiomer of citalopram, which is now off-patent, and a recent Drug and Therapeutics Bulletin2 highlighted how such drugs are developed and marketed after the patent expiry of the originator drug, to extend profits. In humans, as pointed out by DTB, there is little evidence that it is any better than any other serotonin reuptake inhibitors, but it is many times more expensive than generic alternatives. Has the gorilla unwittingly been experimented on in this way as a result of drug company marketing?
Competing interests: MD is on the editorial board for Drug and Therapeutics Bulletin.
Martin Duerden, general practitioner
Meddygfa Gyffin, Conwy, North Wales LL32 8LT
martin@theduerdens.co.uk